Follow-on biologics/biosimilars are defined as which type of drugs?

Study for the BCPS Regulatory Test. Prepare with flashcards and multiple choice questions, each question includes hints and explanations to get you ready for the exam!

Multiple Choice

Follow-on biologics/biosimilars are defined as which type of drugs?

Explanation:
Biosimilars are drugs produced in living cells. Biologics are large, complex molecules—proteins or protein-based therapies—made using biotechnology in cell culture, rather than being chemically synthesized like small-molecule drugs. Because of their complexity and the way they’re produced, exact copies aren’t feasible, so biosimilars are “highly similar” to the reference product with no clinically meaningful differences in safety, purity, or potency, proven through a stepwise comparability program. This is different from small-molecule generics, which are chemically identical copies of simple drugs. It’s also not about over-the-counter analgesics or herbal supplements, which fall into different, non-biologic categories.

Biosimilars are drugs produced in living cells. Biologics are large, complex molecules—proteins or protein-based therapies—made using biotechnology in cell culture, rather than being chemically synthesized like small-molecule drugs. Because of their complexity and the way they’re produced, exact copies aren’t feasible, so biosimilars are “highly similar” to the reference product with no clinically meaningful differences in safety, purity, or potency, proven through a stepwise comparability program.

This is different from small-molecule generics, which are chemically identical copies of simple drugs. It’s also not about over-the-counter analgesics or herbal supplements, which fall into different, non-biologic categories.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy